11/3/03
Total Hits: 1
-
[1] fr03no03N Shani Distributors Denial of Application
- Size: 24024 , Score: 164 , HTML
11/4/03
Total Hits: 1
-
[1] fr04no03N Draft Guidance for Industry on Pharmacogenomic Data Submissions;
- Size: 11718 , Score: 659 , HTML
11/5/03
Total Hits: 1
-
[1] fr05no03N Agency Information Collection Activities; Submission for Office
- Size: 8739 , Score: 707 , HTML
11/6/03
Total Hits: 1
-
[1] fr06no03N Determination That Hyaluronidase For Injection Was Not Withdrawn
- Size: 5573 , Score: 370 , HTML
11/7/03
Total Hits: 1
-
[1] fr07no03N Draft Guidance for Industry on Powder Blends and Finished Dosage
- Size: 5936 , Score: 547 , HTML
11/10/03
Total Hits: 1
-
[1] fr10no03N Determination That Delcobese (Amphetamine Adipate, Amphetamine
- Size: 6983 , Score: 358 , HTML
11/11/03
Total Hits: 0
11/12/03
Total Hits: 0
11/13/03
Total Hits: 1
-
[1] fr13no03N International Conference on Harmonisation; Final Recommendations
- Size: 10702 , Score: 670 , HTML
11/14/03
Total Hits: 1
-
[1] fr14no03N International Conference on Harmonisation; Revised Guidance on
- Size: 9993 , Score: 766 , HTML
11/17/03
Total Hits: 0
11/18/03
Total Hits: 5
-
[1] fr18no03N Anesthetic and Life Support Drugs Advisory Committee; Amendment
- Size: 2166 , Score: 431 , HTML
[2] fr18no03N Oncologic Drugs Advisory Committee; Notice of Meeting
- Size: 3341 , Score: 401 , HTML
[3] fr18no03N Cardiovascular and Renal Drugs Advisory Committee; Notice of
- Size: 3650 , Score: 396 , HTML
[4] fr18no03N Drug Safety and Risk Management Advisory Committee; Notice of
- Size: 3835 , Score: 392 , HTML
[5] fr18no03N Determination That Diclofenac Potassium 25-Milligram Tablet Was
- Size: 4736 , Score: 378 , HTML
11/19/03
Total Hits: 0
11/20/03
Total Hits: 1
-
[1] fr20no03N Agency Information Collection Activities; Proposed Collection;
- Size: 12410 , Score: 416 , HTML
11/21/03
Total Hits: 1
-
[1] fr21no03N International Conference on Harmonisation; Stability Data Package
- Size: 10001 , Score: 763 , HTML
11/24/03
Total Hits: 0
11/25/03
Total Hits: 2
-
[1] fr25no03N Joint Meeting of the Nonprescription Drugs Advisory Committee and
- Size: 4730 , Score: 1000 , HTML
[2] fr25no03N Determination of Regulatory Review Period for Purposes of Patent
- Size: 7044 , Score: 942 , HTML
11/26/03
Total Hits: 1
-
[1] fr26no03N Determination of Regulatory Review Period for Purposes of Patent
- Size: 6764 , Score: 948 , HTML
11/27/03
Total Hits: 0
11/28/03
Total Hits: 0
 |